Manoj Kumar Kingsley, Borkman April, Kim Ashley, Crowder Rebecca, Ajide Bukola, Alí-Francia Karla, Chirwa Masuzyo, Kamulegeya Louis, Le Hien, Trung Vu Ngoc, Venter Rouxjeane, Bimba John, Christopher Devasahayam J, Dalay Victoria, Van Hung Nguyen, Muyoyeta Monde, Nakiyingi Lydia, Van Nhung Nguyen, Theron Grant, Yu Charles, Zamudio-Fuertes Carlos, Atim Julian, Kerkhoff Andrew D, Castro Noriega Maria Del Mar, Nahid Payam, Denkinger Claudia M, Cattamanchi Adithya, Dorman Susan E, West Nora
Department of Pulmonary Medicine, Christian Medical College, Vellore, Tamil Nadu, India.
Medical University of South Carolina, Division of Infectious Diseases, Charleston, South Carolina, United States of America.
medRxiv. 2025 Jul 5:2025.07.04.25330895. doi: 10.1101/2025.07.04.25330895.
Sputum collection for tuberculosis (TB) diagnosis poses challenges for children, people living with HIV, and those who struggle with sputum production. Tongue swab-based molecular testing offers a promising non-invasive alternative, but person-centered research on acceptability is limited.
We conducted a pragmatic survey across eight countries (Vietnam, Philippines, South Africa, Nigeria, Zambia, India, Uganda, Peru) among people with presumptive TB attending primary care facilities. Participants provided both tongue swab and sputum samples, then completed a 5-10 minute survey about their collection preferences.
From October 2023 to July 2024, 1,297 participants were enrolled (median age 43 years, 45% female, 13% HIV-positive). Overall, 61% (95% CI: 58-64%) preferred tongue swab collection compared to 22% (95% CI: 20-25%) who preferred sputum collection and 17% (95% CI: 15-19%) with no preference. Preference for tongue swab was consistent across demographic and clinical subgroups, with country-level variation ranging from 47% in South Africa to 74% in Zambia and Nigeria.
Strong preference for tongue swab over sputum collection among individuals with presumptive TB supports this diagnostic innovation's potential to overcome barriers to timely TB testing, particularly for populations struggling with sputum production.
痰液采集用于结核病诊断对儿童、艾滋病毒感染者以及咳痰困难者来说具有挑战性。基于舌拭子的分子检测提供了一种有前景的非侵入性替代方法,但以患者为中心的可接受性研究有限。
我们在八个国家(越南、菲律宾、南非、尼日利亚、赞比亚、印度、乌干达、秘鲁)对到初级保健机构就诊的疑似结核病患者进行了一项实用调查。参与者同时提供舌拭子和痰液样本,然后完成一项关于他们采集偏好的5至10分钟的调查。
2023年10月至2024年7月,共招募了1297名参与者(中位年龄43岁,45%为女性,13%为艾滋病毒阳性)。总体而言,61%(95%置信区间:58 - 64%)的人更喜欢舌拭子采集,相比之下,22%(95%置信区间:20 - 25%)的人更喜欢痰液采集,17%(95%置信区间:15 - 19%)的人无偏好。在不同人口统计学和临床亚组中,对舌拭子的偏好是一致的,国家层面的差异从南非的47%到赞比亚和尼日利亚的74%不等。
疑似结核病患者对舌拭子采集的偏好明显高于痰液采集,这支持了这种诊断创新方法有潜力克服及时进行结核病检测的障碍,特别是对于咳痰困难的人群。